Embracing the “Fail Fast” Approach for Optimal Resource Allocation To Accelerate Clinical Success
Time: 12:05 pm
day: Day One Track B
Details:
- Recognizing non-viable drug candidates at an early stage for swift reallocation of resources to minimize financial risks and avoid wasteful prolonged investments
- Streamlining trial timelines through agility in adapting to trial dynamics and ensuring a faster and more efficient drug development process
- Addressing time efficiency as a business driver for reduced financial burden in clinical trials
